BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37640958)

  • 21. Beta
    Hostrup M; Reitelseder S; Jessen S; Kalsen A; Nyberg M; Egelund J; Kreiberg M; Kristensen CM; Thomassen M; Pilegaard H; Backer V; Jacobson GA; Holm L; Bangsbo J
    J Physiol; 2018 Sep; 596(17):4121-4139. PubMed ID: 29968301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhaled formoterol impairs aerobic exercise capacity in endurance-trained individuals: a randomised controlled trial.
    Jessen S; Lemminger A; Backer V; Fischer M; Di Credico A; Breenfeldt Andersen A; Bangsbo J; Hostrup M
    ERJ Open Res; 2023 Mar; 9(2):. PubMed ID: 37101738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vilanterol and fluticasone furoate for asthma.
    Dwan K; Milan SJ; Bax L; Walters N; Powell C
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD010758. PubMed ID: 27582089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study, a randomised controlled trial.
    Frith PA; Thompson PJ; Ratnavadivel R; Chang CL; Bremner P; Day P; Frenzel C; Kurstjens N;
    Thorax; 2015 Jun; 70(6):519-27. PubMed ID: 25841237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of inhaled salbutamol in exercising non-asthmatic athletes.
    Goubault C; Perault MC; Leleu E; Bouquet S; Legros P; Vandel B; Denjean A
    Thorax; 2001 Sep; 56(9):675-9. PubMed ID: 11514686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled beta2 agonists and performance in competitive athletes.
    Kindermann W; Meyer T
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i43-7. PubMed ID: 16799103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.
    Main C; Shepherd J; Anderson R; Rogers G; Thompson-Coon J; Liu Z; Hartwell D; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(20):1-174, iii-iv. PubMed ID: 18485272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease.
    McCrory DC; Brown CD
    Cochrane Database Syst Rev; 2001; 2001(2):CD002984. PubMed ID: 11406052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of formoterol, a long-acting β2-adrenergic agonist, on muscle strength and power output, metabolism, and fatigue during maximal sprinting in men.
    Kalsen A; Hostrup M; Backer V; Bangsbo J
    Am J Physiol Regul Integr Comp Physiol; 2016 Jun; 310(11):R1312-21. PubMed ID: 27147617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. beta2-Agonists at the Olympic Games.
    Fitch KD
    Clin Rev Allergy Immunol; 2006; 31(2-3):259-68. PubMed ID: 17085798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma.
    Bjermer L; Rosenborg J; Bengtsson T; Lötvall J
    Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
    Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.
    Wechsler ME; Kunselman SJ; Chinchilli VM; Bleecker E; Boushey HA; Calhoun WJ; Ameredes BT; Castro M; Craig TJ; Denlinger L; Fahy JV; Jarjour N; Kazani S; Kim S; Kraft M; Lazarus SC; Lemanske RF; Markezich A; Martin RJ; Permaul P; Peters SP; Ramsdell J; Sorkness CA; Sutherland ER; Szefler SJ; Walter MJ; Wasserman SI; Israel E;
    Lancet; 2009 Nov; 374(9703):1754-64. PubMed ID: 19932356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
    Sovani MP; Whale CI; Tattersfield AE
    Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anabolic and lipolytic actions of beta
    Hostrup M; Jacobson GA; Jessen S; Lemminger AK
    Drug Test Anal; 2020 May; 12(5):597-609. PubMed ID: 31960603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of salbutamol and caffeine ingestion on exercise metabolism and performance.
    Collomp K; Candau R; Millet G; Mucci P; Borrani F; Préfaut C; De Ceaurriz J
    Int J Sports Med; 2002 Nov; 23(8):549-54. PubMed ID: 12439769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer.
    Lecaillon JB; Kaiser G; Palmisano M; Morgan J; Della Cioppa G
    Eur J Clin Pharmacol; 1999 Apr; 55(2):131-8. PubMed ID: 10335908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose inhaled salbutamol has no acute effects on aerobic capacity or oxygen uptake kinetics in healthy trained men.
    Elers J; Mørkeberg J; Jansen T; Belhage B; Backer V
    Scand J Med Sci Sports; 2012 Apr; 22(2):232-9. PubMed ID: 21083771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.